Advent International to acquire controlling stake in RA Chem Pharma from Micro Labs
The transaction is Advent’s sixth investment in the healthcare sector and seventh investment in India over the past twelve months
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Deals
UK strikes deal with GSK and Sanofi for 60 mn doses of COVID-19 vaccine
The British government said the latest deal helps grow the country’s portfolio of vaccine candidates and adds to previous…
Piramal Pharma Solutions to provide Bolt Biotherapeutics with immune-stimulating antibody conjugates…
Bolt’s Boltbody Immune Stimulating Antibody Conjugate (ISAC), BDC-1001, is currently in a first-in-human Phase 1/2 clinical study…
Sun Pharma arm to acquire Aquinox Pharmaceuticals (Canada)
The cost of acquisition is about $8.2 million
Canada subsidiary of Natco Pharma in settlement agreement with Celgene for onco drug
The terms of the agreement are confidential as per the agreement
Caplin Steriles signs distribution agreement with Xellia Pharmaceuticals
The former to license five of its injectable ANDAs to Xellia Pharmaceuticals for commercialisation in the US
KKR to acquire controlling stake in JB Chemicals and Pharmaceuticals
KKR will make the investment through its subsidiaries, Tau Investments Holdings, Tau Holdco, and KKR Asia III Fund Investments
G1 Therapeutics and Genor Biopharma sign agreement for Lerociclib
As per the exclusive license agreement, Genor to lead clinical development, regulatory submissions and commercialisation of…
DKSH to commercialise seven generic formulations of Biocon Pharma in Singapore and Thailand
The formulations belong to various therapeutic areas like diabetology, cardiology, oncology and immunology
Piramal Pharma to acquire manufacturing facility from G&W Laboratories in the US
Located in Sellersville, Pennsylvania, this facility will broaden the offering of Piramal Pharma Solutions (PPS) by adding solid…
Dr Reddy’s Laboratories completes acquisition of Wockhardt’s select business divisions
The acquired divisions comprise a portfolio of 62 brands in multiple therapy areas such as respiratory, neurology, VMS,…
Cipla acquires stake in GoApptiv
The acquisition of 21.85 per cent stake on a fully diluted basis will be completed in two stages
SPARC and Sun Pharma enter into license agreement for SCD-044
It is a potential treatment for atopic dermatitis, psoriasis and other auto-immune disorders
Boehringer Ingelheim acquires Northern Biologics’ preclinical cancer antibody pipeline
The acquisition provides assets targeting tumour stroma and myeloid cells
The Carlyle Group to acquire majority stake in SeQuent Scientific
The transaction is expected to close in the third quarter of 2020
Pharma industry witnesses 50 deals worth $3 billion in April 2020
Three major deals contributed 72 per cent of deal value in April 2020
Cadila Healthcare to sell stake in Windlas Healthcare to Windlas Biotech for Rs 99.44 cr
The sale is expected to be completed within 10 business days
Zenfold Ventures takes equity stake in Esperer Onco Nutrition
Over the next two years, Esperer Onco Nutrition plans to have more technical collaborations with international technical…
Healthcare industry reports 56 deals worth $2.3-bn in Feb’20
The healthcare industry reported 62 VC deals worth US$0.9-bn in February 2020, compared to the last 12-month average (February…
Healthcare industry reports 70 deals worth $3.2-bn in Jan ’20
The healthcare industry reported 98 VC deals worth $1.9-billion in January 2020, compared to the last 12-month average of 103…